Jci_page_head_homepage_01 Jci_page_head_homepage_02
Christopher Kornfeld, Mickaël J.-Y. Ploquin, Ivona Pandrea, Abdourahmane Faye, Richard Onanga, Cristian Apetrei, Virginie Poaty-Mavoungou, Pierre Rouquet, Jérôme Estaquier, Lorenzo Mortara, Jean-François Desoutter, Cécile Butor, Roger Le Grand, Pierre Roques, François Simon, Françoise Barré-Sinoussi, Ousmane M. Diop, Michaela C. Müller-Trutwin
Published in Volume 115, Issue 4
J Clin Invest. 2005; 115(4):1082–1091 doi:10.1172/JCI23006
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 7

Assessment of CD25+ T cell percentages and of the expression levels of FoxP3 and TGF-β1. (A) CD4+CD25+ T cell percentages within lymphocytes of 6 SIVagm-infected AGMs (SAB97008, SAB98013, SAB00020, SAB01013, SAB01015, and SAB02003). (B) CD8+CD25+ T cell percentages within lymphocytes of these AGMs. (C) FoxP3 gene expression in PBMCs of these AGMs. (D) TGF-β1 gene expression in PBMCs of these AGMs. (E) Concentrations of TGF-β1 in plasma of these 6 AGMs. (F) Concentrations of TGF-β1 in plasma of 6 SIVmac251-infected rhesus macaques. See also legend to Figure 6 for medium gray and dark gray boxes.